Generalized Cost-Effectiveness Analysis to Assess Treatment Value in Hepatitis C
The American Journal of Managed Care · 2023
DOI: 10.37765/ajmc.2023.89468 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Managed Care, 2023. Verfasst von Jacquelyn W Chou und 5 weiteren Autor:innen. Beteiligte Einrichtung: PRECISIONheor, 2 Bethesda Metro Center, Ste 850, Bethesda, MD 20814. Email: jacki.chou@precisionvh.com. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Hepatitis C. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- PRECISIONheor, 2 Bethesda Metro Center, Ste 850, Bethesda, MD 20814. Email: jacki.chou@precisionvh.com.
Zitieren
APA
Chou, J. W., Graf, M., Díaz Espinosa, O., Brewer, I., Heim, Z., & Baumgardner, J. (2023). Generalized Cost-Effectiveness Analysis to Assess Treatment Value in Hepatitis C. The American Journal of Managed Care. https://doi.org/10.37765/ajmc.2023.89468
Vancouver
Chou JW, Graf M, Díaz Espinosa O, Brewer I, Heim Z, Baumgardner J. Generalized Cost-Effectiveness Analysis to Assess Treatment Value in Hepatitis C. The American Journal of Managed Care. 2023. doi:10.37765/ajmc.2023.89468
BibTeX
@article{Chou2023,
author = {Chou, Jacquelyn W and Graf, Marlon and Díaz Espinosa, Oliver and Brewer, Iris and Heim, Zachary and Baumgardner, James},
title = {Generalized Cost-Effectiveness Analysis to Assess Treatment Value in Hepatitis C},
journal = {The American Journal of Managed Care},
year = {2023},
doi = {10.37765/ajmc.2023.89468}
}
EUVIMED